Founded in 2016, CDG Capital focuses on innovative value-investing and constant value-creation for portfolio companies and pursues investments spanning all phases of private equity investment, targeting healthcare, high-end manufacturing, and TMT sectors.
CDG Capital believes that "Still waters run deep" and advocates "Reflect carefully, Practice earnestly", strives for excellence in both professional knowledge and diligent investment implementation. CDG Capital carefully identifies potential industry leaders and commits to grow with them through close collaboration and post-investment empowerment, accelerating technology innovation and industrial transformation.
Relying on the precise judgment from its investment professionals and industry resources, CDG Capital has invested in many outstanding companies, including Innovent Biologics, Akeso Biopharma, MicroPort CardioFlow, RemeGen, Grail, Farasis Energy, etc.
WeChat Official Account
Suite 4704, Central Plaza, 18 Harbour Road, Wanchai, Hong Kong
Tel:852 3520 0635
©️ 2020 All Rights Reserved 晨岭资本有限公司 版权所有 粤ICP备2020113789号